# Arcturus Therapeutics Holdings Inc. (ARCT) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Arcturus Therapeutics Holdings Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ARCT/mda/fy2025/): filed 2026-03-03; accession 0001193125-26-088391 (https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/ARCT/mda/fy2024/): filed 2025-03-06; accession 0000950170-25-034787 (https://www.sec.gov/Archives/edgar/data/1768224/000095017025034787/arct-20241231.htm)
- [FY 2023 MD&A](/company/ARCT/mda/fy2023/): filed 2024-03-14; accession 0000950170-24-031156 (https://www.sec.gov/Archives/edgar/data/1768224/000095017024031156/arct-20231231.htm)
- [FY 2022 MD&A](/company/ARCT/mda/fy2022/): filed 2023-03-29; accession 0000950170-23-010380 (https://www.sec.gov/Archives/edgar/data/1768224/000095017023010380/arct-20221231.htm)
- [FY 2021 MD&A](/company/ARCT/mda/fy2021/): filed 2022-03-01; accession 0001564590-22-007832 (https://www.sec.gov/Archives/edgar/data/1768224/000156459022007832/arct-10k_20211231.htm)

Back to /company/ARCT/